Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of a grass pollen sublingual tablet in children and adolescents with rhinoconjunctivitis/…
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of a grass pollen sublingual tablet in adults with allergic rhinitis with conjunctivi…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: A Phase 1 Scintigraphy Study to Assess Nasal Deposition of Ciclesonide. Using a Novel Nasal Metered Dose Inhaler [Phase 1]
Phase 1 scintigraphy study evaluating nasal deposition of ciclesonide using a novel nasal metered-dose inhaler in allergic rhinitis patients…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Omnaris Versus Levocetirizine Phase 4 Study [Phase 4]
A Phase 4 trial comparing Omnaris (ciclesonide) to levocetirizine for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition [Phase 1]
Phase 1 bioequivalence study comparing Montelukast Sodium chewable tablets 4 mg and 5 mg under fed conditions in healthy volunteers has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Biological Standardization of Lolium Perenne Allergen Extract [Phase 2]
Phase 2 update on the biological standardization of Lolium perenne grass pollen allergen extract, sponsored by Laboratorios Leti, S.L., for …
-
FDA approval · 2012-08-23FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approves a supplemental NDA for Allegra-D Allergy and Congestion, submitted by Chattem, Inc., concerning fexofenadine hydrochloride and …
-
FDA approval · 2012-08-23FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application to update the labeling for Children's Allegra Allergy (fexofenadine hydrochloride), expanding its pe…
-
CLINICAL_TRIALS trial_result · 2012-08-23Clinical Trial Update: Theophylline in Rhinitis [Phase 2]
Phase 2 trial of Theophylline for rhinosinusitis/allergic rhinitis and asthma has completed.
-
FDA approval · 2012-08-21FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate) from Haleon US Holdings LLC.
-
FDA approval · 2012-08-10FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) submitted by Viatris Specialty LLC…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Biological Standardization of Secale Cereale Allergen Extract [Phase 2]
Phase 2 trial completed evaluating the biological standardization of Secale cereale allergen extract for grass pollen allergy.
-
CLINICAL_TRIALS trial_result · 2012-08-07Clinical Trial Update: Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR) [Phase 4]
Phase 4 clinical trial evaluating the effect of Triamcinolone Acetonide on growth velocity in children aged 3 to 9 with perennial allergic r…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge [Phase 4]
A Phase 4 clinical trial investigating allergic inflammation in rhinitis patients after nasal allergen challenge has completed.
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for a generic montelukast sodium product from Rising Pharma Holdings, Inc. under ANDA 202468.
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST — Original Application (Sandoz Inc)
FDA approved Sandoz's original ANDA for montelukast, establishing a generic version of the leukotriene receptor antagonist for prevention of…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Lannett Company, Inc.)
FDA approves the original application for Montelukast Sodium (generic montelukast) manufactured by Lannett Company, Inc. The approval enable…
-
FDA approval · 2012-08-03FDA Approved: MONTELUKAST SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's original ANDA for montelukast sodium, establishing a generic version of montelukast for the a…
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Effect Of Probiotic Lactobacillus Paracasei Lp-33 For The Management Of Rhinitis In People Sensitized To Allergens [Phase 3]
A Phase 3 trial evaluating the probiotic Lactobacillus paracasei Lp-33 for managing allergic rhinitis in individuals sensitized to allergens…
-
FDA approval · 2012-07-16FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
FDA approval · 2012-06-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for levocetirizine dihydrochloride, a generic antihistamine. It is indicated for a…
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE — Original Application (Cranbury Pharmaceuticals, LLC)
FDA approved Cranbury Pharmaceuticals' generic Promethazine hydrochloride and dextromethorphan hydrobromide product under an Original Applic…
-
FDA approval · 2012-06-28FDA Approved: PROMETHAZINE HYDROCHLORIDE — Original Application (Cranbury Pharmaceuticals, LLC)
The FDA approved Promethazine hydrochloride as an original generic drug application (ANDA) for Cranbury Pharmaceuticals, LLC.
-
CLINICAL_TRIALS withdrawal · 2012-06-12Clinical Trial Update: Azelastine Fluticasone Combination vs. Fluticasone [Phase 4]
A Phase 4 trial comparing an azelastine/fluticasone combination with fluticasone alone for allergic rhinitis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Controlled Exposure to Diesel Exhaust in Subjects With Allergic Rhinitis [NA]
This clinical trial update reports a study evaluating controlled exposure to diesel exhaust in subjects with allergic rhinitis. The trial st…